OT-A201

· Onward Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OT-A201, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors [Phase 1]